🔎 Trials Near Me

Utama › Penyakit Alzheimer › California › Los Angeles

Kajian klinikal Penyakit Alzheimer di Los Angeles, CA

14 kajian untuk Penyakit Alzheimer sedang mencari peserta di lokasi dalam dan sekitar Los Angeles (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

A Study of LY3439539 in Participants With Alzheimer's Disease

Mengambil pesertaFasa 1
  • Inglewood Clinical, Los Angeles
Umur 50 hingga 85 · Semua jantina · Dikemas kini 24 Sep 2026 · NCT07598370

A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

Mengambil pesertaFasa 3
  • USC - The Memory and Aging Center (MAC) - Alzheimer Disease Research Center (ADRC), Los Angeles
Umur 55 hingga 90 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT06585787

Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

Mengambil pesertaFasa 3
  • Inglewood Clinicals, Los Angeles
Umur 50 hingga 90 · Semua jantina · Dikemas kini 21 Sep 2026 · NCT07177352

A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)

Mengambil pesertaFasa 3
  • Inglewood Clinical, Los Angeles
Umur 60 hingga 85 · Semua jantina · Dikemas kini 17 Sep 2026 · NCT06976203

Large-coil Parietal Repetitive Transcranial Magnetic Stimulation (rTMS) for Alzheimer Disease (AD)

Mengambil pesertaFasa 1/2
  • UCLA TMS Clinical and Research Service, Los Angeles
Umur 55 hingga 100 · Semua jantina · Dikemas kini 4 Sep 2026 · NCT06597942

A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)

Mengambil pesertaFasa 2
  • Inglewood Clinical ( Site 1062), Los Angeles
Umur 50 hingga 85 · Semua jantina · Dikemas kini 26 Ogo 2026 · NCT07033494

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

Mengambil pesertaFasa 3
  • University of California, Los Angeles (UCLA) - David Geffen School of Medicine, Los Angeles
Umur 18 hingga 75 · Semua jantina · Dikemas kini 4 Ogo 2026 · NCT06563895

A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

Mengambil pesertaFasa 2/3Sukarelawan sihat dialu-alukan
  • University of Southern Califonria, Los Angeles
Umur 18 ke atas · Semua jantina · Dikemas kini 27 Jul 2026 · NCT05552157

A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

Mengambil pesertaFasa 2/3Sukarelawan sihat dialu-alukan
  • University of Southern Califonria, Los Angeles
Umur 18 ke atas · Semua jantina · Dikemas kini 27 Jul 2026 · NCT06647498

A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease

Mengambil pesertaFasa 2
  • University of California at Los Angeles, Los Angeles
Umur 50 hingga 85 · Semua jantina · Dikemas kini 26 Jun 2026 · NCT07094516

Polyphenols and Cognitive Decline

Mengambil pesertaSukarelawan sihat dialu-alukan
  • University of California, Los Angeles, Los Angeles
Umur 50 ke atas · Semua jantina · Dikemas kini 11 Jun 2026 · NCT06507254

[18F]PI-2620 Phase 3 Histopathological Study

Mengambil pesertaFasa 3
  • UC Los Angeles, Los Angeles
Umur 50 ke atas · Semua jantina · Dikemas kini 22 Mei 2026 · NCT05641688

Cardiac-Control Affecting Learning Through Mindfulness (CALM)

Mengambil pesertaSukarelawan sihat dialu-alukan
  • University of Southern California, Los Angeles
Umur 50 hingga 70 · Semua jantina · Dikemas kini 13 Mei 2026 · NCT06410157

Transcranial Photobiomodulation (tPBM) in Alzheimer's Disease Study

Mengambil peserta
  • CSMC, Los Angeles
Umur 55 hingga 89 · Semua jantina · Dikemas kini 19 Nov 2025 · NCT07224607

Kajian Penyakit Alzheimer di bandar lain

Kajian lain di Los Angeles

Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.